LUXEMBOURG, Sept 8 (Reuters) - Danish drugmaker Lundbeck's
deals with smaller rivals to delay cheaper generic
copies of its blockbuster citalopram anti-depressant from
entering the market were anti-competitive, a European Union
court said on Thursday.
Read more
No comments:
Post a Comment